Propanc Biopharma Statistics
Total Valuation
PPCB has a market cap or net worth of $3.21 million. The enterprise value is $2.89 million.
| Market Cap | 3.21M |
| Enterprise Value | 2.89M |
Important Dates
The last earnings date was Tuesday, September 29, 2026, before market open.
| Earnings Date | Sep 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PPCB has 6.33 million shares outstanding. The number of shares has increased by 607.95% in one year.
| Current Share Class | 6.33M |
| Shares Outstanding | 6.33M |
| Shares Change (YoY) | +607.95% |
| Shares Change (QoQ) | +187.37% |
| Owned by Insiders (%) | 14.66% |
| Owned by Institutions (%) | 1.07% |
| Float | 5.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.55 |
| Quick Ratio | 0.25 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.24 |
Financial Efficiency
Return on equity (ROE) is -161.86% and return on invested capital (ROIC) is -88.99%.
| Return on Equity (ROE) | -161.86% |
| Return on Assets (ROA) | -70.14% |
| Return on Invested Capital (ROIC) | -88.99% |
| Return on Capital Employed (ROCE) | -192.94% |
| Weighted Average Cost of Capital (WACC) | 28.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$9.90M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.81% in the last 52 weeks. The beta is 3.33, so PPCB's price volatility has been higher than the market average.
| Beta (5Y) | 3.33 |
| 52-Week Price Change | -98.81% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 3.75 |
| Relative Strength Index (RSI) | 33.19 |
| Average Volume (20 Days) | 269,716 |
Short Selling Information
The latest short interest is 29,003, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 29,003 |
| Short Previous Month | 335,967 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 0.54% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.19M |
| Pretax Income | -18.86M |
| Net Income | -19.79M |
| EBITDA | -18.18M |
| EBIT | -18.19M |
| Earnings Per Share (EPS) | -$17.62 |
Balance Sheet
The company has $832,006 in cash and $509,116 in debt, with a net cash position of $322,890 or $0.05 per share.
| Cash & Cash Equivalents | 832,006 |
| Total Debt | 509,116 |
| Net Cash | 322,890 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 9.40M |
| Book Value Per Share | 2.84 |
| Working Capital | 5.19M |
Cash Flow
In the last 12 months, operating cash flow was -$5.68 million and capital expenditures -$4,933, giving a free cash flow of -$5.69 million.
| Operating Cash Flow | -5.68M |
| Capital Expenditures | -4,933 |
| Depreciation & Amortization | 997 |
| Net Borrowing | -807,259 |
| Free Cash Flow | -5.69M |
| FCF Per Share | -$0.90 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PPCB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -607.95% |
| Shareholder Yield | -607.95% |
| Earnings Yield | -616.08% |
| FCF Yield | -177.02% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 18, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | May 18, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |